Sarcoidosis - Cleveland Clinic Center for Continuing Education

More documents

Recommendations

Info

Treatment <strong>for</strong> <strong>Sarcoidosis</strong> • Which patient ? • Which drug ? • Which dose ? • Which tapering ? • Which duration ? • Which assessment ?
Natural history of sarcoidosis • Spontaneous remission: 60 - 70% • Chronic or progressive course: 10 - 30% • Serious extrapulmonary involvement at presentation: 4 - 7% • Permanent sequelae: 10 - 20% • Mortality: 1 - 5% (respiratory, central nervous, cardiac)
Page 1 and 2:
Sarcoidosis around the world: Past,
Page 3 and 4:
Historical development of sarcoidos
Page 5 and 6:
Sarcoidosis of the skin, described
Page 7:
Sarcoidosis milestones (1) • 1869
Page 10 and 11:
In 1899 Caesar Boeck published his
Page 12 and 13:
Otto Jüngling (1884-1944) Publishe
Page 14 and 15:
Sarcoidosis milestones (2) 1941 A.
Page 16 and 17:
The participants to the 1st Interna
Page 18 and 19:
International Conferences on Sarcoi
Page 20 and 21:
Hot topics of the 10th Internationa
Page 22:
Om P. Sharma Chairman
Page 25:
5th WASOG Meeting Essen 1997
Page 30:
9th WASOG Meeting & 11th BAL Congre
Page 34:
To assess health status and quality
Page 38 and 39:
Contents of SARCOIDOSIS Vol. 1, No.
Page 46 and 47:
Sarcoidosis: Past, Present, Future
Page 48 and 49:
1991 Definition of sarcoidosis incl
Page 50 and 51:
Definition of sarcoidosis • Sarco
Page 52 and 53:
Comparison Finland vs Hokkaido, Jap
Page 54 and 55:
Normalisation of chest x ray over 5
Page 56 and 57:
Page 58 and 59:
HLA-types and Sarcoidosis “Protec
Page 60 and 61:
Resolved (%) Resolution of Löfgren
Page 62 and 63:
Percent of patients Heerfordt´s sy
Page 64 and 65:
What are potential causative agents
Page 66 and 67:
Etiological triggers • Role of my
Page 68 and 69:
Spot forming cells/million PBMC T-c
Page 70 and 71:
Page 72 and 73:
Hypercalcemia in Sarcoidosis • 19
Page 74 and 75:
Immunology of sarcoidosis: Discrepa
Page 76 and 77:
Compartmentalized Immune Response i
Page 78 and 79:
Page 80 and 81:
Diagnostic approach The diagnosis o
Page 82 and 83: Sarcoidosis: a systemic disease •
Page 84 and 85: Fatigue: a major problem Four types
Page 86 and 87: Measurements: systemic response •
Page 88 and 89: The changing tools for diagnosing s
Page 91 and 92: Mediastinoscopy in patients with pr
Page 93: 33,000 Mediastinoscopies for BHL Co
Page 98 and 99: BAL Profile in Sarcoidosis • Lymp
Page 100 and 101: J. Chrétien C. Voisin Lille, Franc
Page 102 and 103: L. Bjermer T Sandström
Page 104 and 105: C. Burke L. Poulter
Page 106 and 107: ... and his fans
Page 108 and 109: Krakow 7th International BAL Confer
Page 110: Carlos Robalo Cordeiro
Page 113: The changing tools for diagnosing s
Page 116 and 117: The changing tools for diagnosing s
Page 118 and 119: TBNA for Diagnosing Sarcoidosis Aut
Page 120 and 121: Endobronchial Ultrasound in Sarcoid
Page 122 and 123: Diagnostic effectiveness of EBUS-TB
Page 124 and 125: Per cent biopsy of involved organ #
Page 126 and 127: Clinical Course • ACCESS study: -
Page 128 and 129: Follow-up for sarcoidosis in resear
Page 130 and 131: Sarcoidosis: Past, Present, Future
Page 134 and 135: Goal of Treatment • Reduce sympto
Page 136 and 137: Indication for treatment of pulmona
Page 138 and 139: Alternative drugs for sarcoidosis
Page 140 and 141: Biological Agents with anti-TNF Act
Page 142 and 143: Lupus Pernio after 4th dose Inflixi
Page 144 and 145: 6 months therapy with Infliximab po
Page 146 and 147: Active recruiting studies for sarco
Page 148 and 149: Areas of Future Research • Discov
Page 150 and 151: Physiology Future scenario for sarc
Page 152:
WASOG Family
show all

Sarcoidosis - Cleveland Clinic Center for Continuing Education

Create successful ePaper yourself

Delete template?

Save as template?